Optical coherence tomography findings in chronic progressive external ophthalmoplegia.
Journal
Chinese medical journal
ISSN: 2542-5641
Titre abrégé: Chin Med J (Engl)
Pays: China
ID NLM: 7513795
Informations de publication
Date de publication:
20 May 2019
20 May 2019
Historique:
entrez:
30
5
2019
pubmed:
30
5
2019
medline:
18
12
2019
Statut:
ppublish
Résumé
Chronic progressive external ophthalmoplegia (CPEO) is a mitochondrial encephalomyopathy caused by multiple mtDNA abnormalities. There is little information about the changes of ocular fundus with CPEO. The aim of this work was to measure and evaluate changes in the macular retinal thickness and optic nerve head in patients with CPEO using spectral-domain optical coherence tomography and to compare the findings with those of healthy individuals. Totally, 18 CPEO patients were enrolled in this study. Healthy volunteers matched for gender, age, and diopter settings were included as a control group. The retinal thickness of macular central fovea, inner and outer retinal layer thickness of perifoveal macular, optic nerve head parameters, and peripapillay retinal nerve fiber layer thickness (pRNFLT) for all included cases were measured using spectral-domain optical coherence tomography. A paired t test was used to compare the differences in the studied parameters between the two groups. The correlations between macular retinal thickness, pRNFLT, disease duration, and age of onset were also analyzed. Among the macular parameters, retinal thickness of macular central fovea (t = -2.135, P < 0.05) and outer retinal layer thickness (t = -1.994, P < 0.05) of patients in the CPEO group were statistically significant lower than those of patients in the normal control group. For the optic nerve head parameters, the patients in the CPEO group showed a larger rim volume (t = -2.499, P < 0.05) and nerve head volume (t = -2.103, P < 0.05). The overall pRNFLT of patients in the CPEO group was statistically significant lower than that of patients in the control group (t = -4.125, P < 0.05). The comparison of pRNFLT in eight sectors showed that the pRNFLT of patients in the CPEO group was statistically significant lower than that of the control group mainly in the inferior and temporal sectors. The degree of pRNFL defect negatively correlated with the disease duration (r = -0.583, P < 0.05). The retinal thickness of patients with CPEO was significantly thinner, which was mostly the outer retina. The patients' optic discs had a low volume and the loss of the retinal nerve fiber layer was obvious. With the extension of the disease duration, the retinal nerve fiber layer defect was even more significant.
Sections du résumé
BACKGROUND
BACKGROUND
Chronic progressive external ophthalmoplegia (CPEO) is a mitochondrial encephalomyopathy caused by multiple mtDNA abnormalities. There is little information about the changes of ocular fundus with CPEO. The aim of this work was to measure and evaluate changes in the macular retinal thickness and optic nerve head in patients with CPEO using spectral-domain optical coherence tomography and to compare the findings with those of healthy individuals.
METHODS
METHODS
Totally, 18 CPEO patients were enrolled in this study. Healthy volunteers matched for gender, age, and diopter settings were included as a control group. The retinal thickness of macular central fovea, inner and outer retinal layer thickness of perifoveal macular, optic nerve head parameters, and peripapillay retinal nerve fiber layer thickness (pRNFLT) for all included cases were measured using spectral-domain optical coherence tomography. A paired t test was used to compare the differences in the studied parameters between the two groups. The correlations between macular retinal thickness, pRNFLT, disease duration, and age of onset were also analyzed.
RESULTS
RESULTS
Among the macular parameters, retinal thickness of macular central fovea (t = -2.135, P < 0.05) and outer retinal layer thickness (t = -1.994, P < 0.05) of patients in the CPEO group were statistically significant lower than those of patients in the normal control group. For the optic nerve head parameters, the patients in the CPEO group showed a larger rim volume (t = -2.499, P < 0.05) and nerve head volume (t = -2.103, P < 0.05). The overall pRNFLT of patients in the CPEO group was statistically significant lower than that of patients in the control group (t = -4.125, P < 0.05). The comparison of pRNFLT in eight sectors showed that the pRNFLT of patients in the CPEO group was statistically significant lower than that of the control group mainly in the inferior and temporal sectors. The degree of pRNFL defect negatively correlated with the disease duration (r = -0.583, P < 0.05).
CONCLUSIONS
CONCLUSIONS
The retinal thickness of patients with CPEO was significantly thinner, which was mostly the outer retina. The patients' optic discs had a low volume and the loss of the retinal nerve fiber layer was obvious. With the extension of the disease duration, the retinal nerve fiber layer defect was even more significant.
Identifiants
pubmed: 31140991
doi: 10.1097/CM9.0000000000000262
pii: 00029330-201905200-00011
pmc: PMC6511415
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1202-1207Références
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2003 Aug;20(4):273-8
pubmed: 12903032
Invest Ophthalmol Vis Sci. 2005 Jul;46(7):2440-3
pubmed: 15980233
J Neuroophthalmol. 2006 Mar;26(1):18-24
pubmed: 16518161
Kidney Int. 2008 Jul;74(2):252
pubmed: 18591951
Ophthalmology. 2009 Jun;116(6):1119-24
pubmed: 19376593
Mitochondrion. 2009 Sep;9(5):314-7
pubmed: 19410662
Clin Ophthalmol. 2009;3:373-9
pubmed: 19668593
Am J Ophthalmol. 2010 Mar;149(3):496-502.e1
pubmed: 20042179
Clin Ophthalmol. 2010 Dec 06;4:1427-32
pubmed: 21188154
J Neuroophthalmol. 2012 Jun;32(2):135-8
pubmed: 22418087
Eur J Neurol. 2013 Jan;20(1):198-201
pubmed: 22436028
J Alzheimers Dis. 2013;34(3):659-64
pubmed: 23271313
Invest Ophthalmol Vis Sci. 2013 Sep 05;54(9):5953-8
pubmed: 23920375
Am J Ophthalmol. 2014 Feb;157(2):470-478.e2
pubmed: 24315296
Front Psychiatry. 2014 Feb 25;5:22
pubmed: 24616709
Eye (Lond). 2014 Jun;28(6):680-90
pubmed: 24625377
J Alzheimers Dis. 2015;45(1):45-56
pubmed: 25428254
Arch Gerontol Geriatr. 2015 Jan-Feb;60(1):162-7
pubmed: 25459918
Neurol Sci. 2015 Jul;36(7):1141-6
pubmed: 25575807
Acta Ophthalmol. 2015 Dec;93(8):e672-7
pubmed: 26066643
Can J Ophthalmol. 2015 Oct;50(5):e85-8
pubmed: 26455989
Am J Alzheimers Dis Other Demen. 2016 Aug;31(5):430-6
pubmed: 26888864
Acta Ophthalmol. 2016 Sep;94(6):e454-9
pubmed: 26895692
Ophthalmic Genet. 2017 Jan-Feb;38(1):67-69
pubmed: 27029465
Alzheimers Dement (Amst). 2015 Apr 23;1(2):136-43
pubmed: 27239501
Alzheimers Dement (Amst). 2016 Aug 19;4:85-93
pubmed: 27722194
Br J Ophthalmol. 1985 Jan;69(1):63-75
pubmed: 3965031
Arch Ophthalmol. 1972 Aug;88(2):155-66
pubmed: 5045490
Neuromuscul Disord. 1995 Sep;5(5):399-413
pubmed: 7496174